Fig. 3From: Large-scale public data reuse to model immunotherapy response and resistanceComparison of biomarkers. The test biomarker is composed of genes with consistent evidence on cancer immune evasion (Additional file 3: Table S3). The area under receiver operating characteristic curve (AUC) is applied to evaluate the prediction performance of the test biomarker on the ICB response statusBack to article page